
Exagen XGN
$ 2.84
2.16%
Annual report 2025
added 03-10-2026
Country |
|
IPO year |
2019 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
21.6 M |
Market Cap[1] |
$ 61.2 M |
EBITDA (LTM) |
$ -11.9 M |
P/E (LTM) |
-2.78 |
P/S (LTM) |
0.96 |
EPS (LTM) |
-1.0 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 8.98 | 3.88 % | $ 598 M | Nasdaq Global Select Market | ||
|
Biomerica
BMRA
|
$ 2.1 | -4.11 % | $ 4.82 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 25.78 | 3.1 % | $ 716 M | Nasdaq Global Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 196.35 | 0.56 % | $ 21.8 B | NYSE,SPB | ||
|
DexCom
DXCM
|
$ 66.44 | -0.77 % | $ 25.9 B | Nasdaq Global Select Market,SPB | ||
|
Brainsway Ltd.
BWAY
|
$ 13.74 | 0.59 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Fulgent Genetics
FLGT
|
$ 16.23 | 4.64 % | $ 491 M | Nasdaq Global Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 104.91 | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.71 | 0.73 % | $ 7.5 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 124.78 | 0.36 % | $ 19.8 B | Nasdaq Global Select Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Lantheus Holdings
LNTH
|
$ 76.14 | -0.38 % | $ 5.14 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 158.54 | 3.28 % | $ 7.86 B | NYSE,SPB | ||
|
IQVIA Holdings
IQV
|
$ 168.88 | 1.68 % | $ 29 B | NYSE,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
IDEXX Laboratories
IDXX
|
$ 583.17 | 1.02 % | $ 46.9 B | Nasdaq Global Select Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.38 | 20.0 % | $ 1.75 M | Nasdaq Capital Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 461.82 | 2.06 % | $ 13.3 B | Nasdaq Global Select Market,SPB | ||
|
Agilent Technologies
A
|
$ 112.67 | 1.23 % | $ 34.3 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 100.65 | 0.95 % | $ 8.3 B | Nasdaq Global Select Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 7.99 | - | $ 31.8 M | Nasdaq Capital Market | ||
|
Guardant Health
GH
|
$ 85.1 | -0.1 % | $ 10.7 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.7 | 2.51 % | $ 435 M | Nasdaq Global Select Market,SPB | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
NeoGenomics
NEO
|
$ 8.12 | 2.01 % | $ 1.04 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 244.73 | 3.38 % | $ 25.7 B | NYSE,SPB | ||
|
National Research Corporation
NRC
|
$ 17.41 | 0.49 % | $ 390 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 200.01 | 2.42 % | $ 19.7 B | Nasdaq Global Select Market,SPB | ||
|
CareDx, Inc
CDNA
|
$ 17.68 | 3.09 % | $ 942 M | Nasdaq Global Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 3.45 | - | $ 1.85 M | Nasdaq Global Select Market | ||
|
OPKO Health
OPK
|
$ 1.12 | - | $ 777 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 106.81 | 0.73 % | $ 4.21 B | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 266.11 | 1.15 % | $ 22.1 B | NYSE,SPB | ||
|
Personalis
PSNL
|
$ 7.55 | 3.99 % | $ 447 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.